Trade Summary

Yesterday, Catinazzo Thomas, serving as CFO at Relay Therapeutics, Inc. (RLAY), sold 17,717 shares at $12.86 per share, for a total transaction value of $227,841.00. Following this transaction, Catinazzo Thomas now holds 195,178 shares of RLAY.

This sale represents a 8.00% decrease in Catinazzo Thomas's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Thursday, May 14, 2026 and publicly disclosed via SEC Form 4 filing on Thursday, May 14, 2026 at 6:44 PM ET, meaning the disclosure happened on the same day as the trade.

Relay Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.